Evaluation of Second-Generation Lipophosphonoxins as Antimicrobial Additives in Bone Cement
Author(s) -
Eva Zbornı́ková,
Jiří Gallo,
Renata Večeřová,
Kateřina Bogdanová,
Milan Kolář,
Dragana Vítovská,
Duy Dinh Do Pham,
Ondřej Pačes,
Viktor Mojr,
Hana Šanderová,
Jitka Ulrichová,
Adéla Galandáková,
Drahomír Čadek,
Zdeněk Hrdlička,
Libor Krásný,
Dominik Rejman
Publication year - 2020
Publication title -
acs omega
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.779
H-Index - 40
ISSN - 2470-1343
DOI - 10.1021/acsomega.9b03072
Subject(s) - bone cement , thermostability , cement , antimicrobial , ultimate tensile strength , materials science , chemistry , nuclear chemistry , composite material , organic chemistry , enzyme
Successful surgeries involving orthopedic implants depend on the avoidance of biofilm development on the implant surface during the early postoperative period. Here, we investigate the potential of novel antibacterial compounds-second-generation lipophosphonoxins (LPPOs II)-as additives to surgical bone cements. We demonstrate (i) excellent thermostability of LPPOs II, which is essential to withstand elevated temperatures during exothermic cement polymerization; (ii) unchanged tensile strength and elongation at the break properties of the composite cements containing LPPOs II compared to cements without additives; (iii) convenient elution kinetics on the order of days; and (iv) the strong antibiofilm activity of the LPPO II-loaded cements even against bacteria resistant to the medicinally utilized antibiotic, gentamicin. Thus, LPPOs II display promising potential as antimicrobial additives to surgical bone cements.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom